Mark G Tegen

Title: Mark G. Tegen: Innovator in Cannabinoid Research

Introduction

Mark G. Tegen, based in Seattle, WA, is a prominent inventor known for his significant contributions to cannabinoid research. With an impressive portfolio of 19 patents, he has established himself as a leading innovator in the field of cannabis-derived compounds.

Latest Patents

One of Tegen's most notable recent patents focuses on the continuous isolation of cannabidiol and cannabinoids, as well as the conversion of cannabidiol into delta 8-tetrahydrocannabinol (Δ8-THC) and delta 9-tetrahydrocannabinol (Δ9-THC). This patent outlines various processes for obtaining or purifying ΔTHC and other cannabinoids or terpenes from natural or synthetic sources. The innovation also includes methods for the continuous isolation and purification of these compounds at an industrial scale, which has significant implications for the cannabis industry.

Career Highlights

Throughout his career, Mark G. Tegen has worked with several noteworthy companies, including Inventure Renewables, Inc. and Inventure Chemical, Inc. His work has consistently focused on developing profitable and scalable processes for cannabinoid extraction and conversion.

Collaborations

Tegen has collaborated with a talented team, including colleagues such as William Rusty Sutterlin and William Wes Berry. These partnerships have facilitated the advancement of innovative processes and technologies in the field of cannabinoid research.

Conclusion

Mark G. Tegen is a pioneering inventor whose work has significantly advanced the understanding and utilization of cannabinoids. With a strong emphasis on innovation and collaboration, his contributions will likely continue to impact the industry and promote the ongoing evolution of cannabis applications.